Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Mar;20(3):212-4.
doi: 10.1089/acm.2013.0130. Epub 2013 Oct 5.

Bee venom treatment for refractory postherpetic neuralgia: a case report

Seung Min Lee  1 , Jinwoong Lim, Jae-Dong Lee, Do-Young Choi, Sanghoon Lee
Affiliations
Case Reports

Bee venom treatment for refractory postherpetic neuralgia: a case report

Seung Min Lee et al. J Altern Complement Med. 2014 Mar.

Abstract

Objective: Bee venom has been reported to have antinociceptive and anti-inflammatory effects in experimental studies. However, questions still remain regarding the clinical use of bee venom. This report describes the successful outcome of bee venom treatment for refractory postherpetic neuralgia.

Patient: A 72-year-old Korean man had severe pain and hypersensitivity in the region where he had developed a herpes zoster rash 2 years earlier. He was treated with antivirals, painkillers, steroids, and analgesic patches, all to no effect.

Intervention: The patient visited the East-West Pain Clinic, Kyung Hee University Medical Center, to receive collaborative treatment. After being evaluated for bee venom compatibility, he was treated with bee venom injections. A 1:30,000 diluted solution of bee venom was injected subcutaneously along the margins of the rash once per week for 4 weeks.

Results: Pain levels were evaluated before every treatment, and by his fifth visit, his pain had decreased from 8 to 2 on a 10-point numerical rating scale. He experienced no adverse effects, and this improvement was maintained at the 3-month, 6-month, and 1-year phone follow-up evaluations.

Conclusion: Bee venom treatment demonstrates the potential to become an effective treatment for postherpetic neuralgia. Further large-sample clinical trials should be conducted to evaluate the overall safety and efficacy of this treatment.

PubMed Disclaimer

References

    1. Weinke T, Edte A, Schmitt S. Impact of herpes zoster and postherpetic neuralgia on patients' quality of life: a patient-reported outcomes survey. J Public Health 2010;18:367–374 - PMC - PubMed
    1. Gershon AA. Epidemiology and management of postherpetic neuralgia. Semin Dermatol 1996;15:8–13 - PubMed
    1. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: Treatment of postherpetic neuralgia: an evidence-based report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2004;63:959–965 - PubMed
    1. Glauser T, Salinas G, Nevins H, et al. Communication gaps between physicians and patients with postherpetic neuralgia: results from a national study on practice patterns. J Pain Res 2011;4:407–415 - PMC - PubMed
    1. Johnson RW, Wasner G, Saddier P, Baron R. Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother 2007;7:1581–1595 - PubMed

Publication types

LinkOut - more resources